Wafik S. El-Deiry, Director of Legorreta Cancer Center at Brown University and Chair of the WIN Consortium in Cancer Personalized Medicine, shared a post on LinkedIn:
“For oncologists, cancer researchers, and all stakeholders
Precision Oncology is here to stay and already impacting practice.
The WIN Consortium in cancer personalized medicine offers opportunity for prospective best-in-class N-of-1 basket trials with AI algorithms to demonstrate patient benefit from combinations of matched targeted cancer therapy with other modalities.
It is important to continue to learn from every patient and provide ongoing evidence to support innovative practice guidelines, approvals, access to testing, cancer drugs and payor reimbursement.
Reach out if you are an investigator with a novel concept for cancer precision therapy, detection, interception or prevention.
WIN can help including with finding collaborators, funding and global implementation.”
More posts featuring Wafik S. El-Deiry on OncoDaily.